Evidence map›Paper›PMID 37325303›Full record

SynthesisFrontiers in public health2023

Caixin Xiang, Jianzhong Zhang, Fei Zhao, Yuanhai You

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Comparing virulence profile of dominantInfectious diseases & immunity · 2026
    Article
  4. Article
  5. Molecular Characterization ofMicroorganisms · 2025
    Article
  6. Polish journal of microbiology · 2025
    Article
  7. Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1The Lancet regional health. Western Pacific · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Caixin XiangSchool of Public Health, China Medical University, Shenyang, Liaoning, China.
Jianzhong ZhangState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Fei ZhaoState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yuanhai YouSchool of Public Health, China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The recent increase of group A Methods: We collected studies reporting GAS Results: 47 high quality studies were included for a systematic analysis of

Indexed as

Antigens, BacterialStreptococcal InfectionsBacterial Outer Membrane ProteinsCarrier ProteinsChinaHumansStreptococcus pyogenesAntigens, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsChinaemm typegroup A Streptococcusprevalent typevaccine coverage

Identifiers

PMID37325303
PMCPMC10262998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.